Spotlight On Subcutaneous Cancer Immunotherapies
Welcome to Spotlight On Subcutaneous Cancer Immunotherapies, your go-to source for the latest updates regarding the potential application of this approach in the oncology space. Hear expert insights on how this particular route of therapeutic administration might help advance cancer care.
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Spotlight On Subcutaneous Cancer ImmunotherapiesNanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Evaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
Spotlight On Subcutaneous Cancer ImmunotherapiesEvaluating Alemtuzumab in Adult ALL: Insights from a Phase 1/2 Clinical Trial
- 03/21/2025